Merus
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Merus and other ETFs, options, and stocks.About MRUS
Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors.
MRUS Key Statistics
Stock Snapshot
With a market cap of 7.3B, Merus(MRUS) trades at $96.02. The stock has a price-to-earnings ratio of -18.00.
During the trading session on 2025-11-25, Merus(MRUS) shares reached a daily high of $96.18 and a low of $95.90. At a current price of $96.02, the stock is +0.1% higher than the low and still -0.2% under the high.
Trading volume for Merus(MRUS) stock has reached 1.68M, versus its average volume of 1.6M.
Over the past 52 weeks, Merus(MRUS) stock has traded between a high of $96.28 and a low of $33.19.
Over the past 52 weeks, Merus(MRUS) stock has traded between a high of $96.28 and a low of $33.19.
MRUS News
H.C. Wainwright analyst Mitchell Kapoor reiterated a Buy rating on Halozyme today and set a price target of $90.00. Meet Your ETF AI Analyst Discover how TipRan...